1-(2-methoxyethyl)-2-[N-(1,3-thiazol-2-yl)-2-(trifluoromethoxy)anilino]benzimidazole-5-carboxylic acid
C21H17F3N4O4S — CID 67333490
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-(2-methoxyethyl)-2-[N-(1,3-thiazol-2-yl)-2-(trifluoromethoxy)anilino]benzimidazole-5-carboxylic acid
1-(2-methoxyethyl)-2-[N-(1,3-thiazol-2-yl)-2-(trifluoromethoxy)anilino]benzimidazole-5-carboxylic acid (PubChem CID 67333490) has the molecular formula C21H17F3N4O4S and a molecular weight of 478.45 g/mol. Its IUPAC name is 1-(2-methoxyethyl)-2-[N-(1,3-thiazol-2-yl)-2-(trifluoromethoxy)anilino]benzimidazole-5-carboxylic acid.
Molecular Properties
| Compound Name | 1-(2-methoxyethyl)-2-[N-(1,3-thiazol-2-yl)-2-(trifluoromethoxy)anilino]benzimidazole-5-carboxylic acid |
|---|---|
| PubChem CID | 67333490 |
| Molecular Formula | C21H17F3N4O4S |
| Molecular Weight | 478.45 g/mol |
| Exact Mass | 478.09 |
| IUPAC Name | 1-(2-methoxyethyl)-2-[N-(1,3-thiazol-2-yl)-2-(trifluoromethoxy)anilino]benzimidazole-5-carboxylic acid |
| SMILES | COCCn1c(N(c2nccs2)c2ccccc2OC(F)(F)F)nc2cc(C(=O)O)ccc21 |
| InChI | InChI=1S/C21H17F3N4O4S/c1-31-10-9-27-15-7-6-13(18(29)30)12-14(15)26-19(27)28(20-25-8-11-33-20)16-4-2-3-5-17(16)32-21(22,23)24/h2-8,11-12H,9-10H2,1H3,(H,29,30) |
| InChIKey | LFXOFPAFONLNBR-UHFFFAOYSA-N |
| XLogP | 5.21 |
| TPSA | 89.71 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 478.45 |
| LogP ≤ 5 | 5.21 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 67333490 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.